The Skin of Color Clinic is devoted to the unique needs of patients of all ethnicities. Photo courtesy of BCM

All skin is created equal, but not all skin behaves the same. It’s with this in mind that Baylor Medicine Dermatology has announced the debut of its newest office.

The Skin of Color Clinic is located inside the Jamail Specialty Care Center and is devoted to the unique needs of patients of all ethnicities.

The leader of the Skin of Color Clinic is assistant professor of dermatology, Oyetewa Oyerinde. Dr. Oyerinde, a Howard University and University of Illinois at Chicago College of Medicine alum, completed her residency training at Harvard University, where she made it to the role of chief resident in her final year.

“I am excited to lead a clinic that addresses skin issues commonly found in underserved populations,” Oyerinde says in a news release. “I want people in Houston to know that there is a place where an expert will know how to care for their specific needs.”

The leader of the Skin of Color Clinic is assistant professor of dermatology, Oyetewa Oyerinde. Photo via bcm.edu

Patients who identify as Black, African American, Latinx, Asian, or Native American all have different skin with varying requirements, which the Skin of Color Clinic will address in a culturally sensitive and competent manner. An awareness that some conditions affect people with darker skin tones differently than people with light skin tones informs the clinic’s work, as does the fact that there are also some diseases that disproportionately affect people of color.

Dr. Oyerinde specializes in issues including hyper- or hypopigmentation, scarring and non-scarring hair loss, acne keloidalis nuchae, and keloids. Meanwhile, Dr. Zeena Nawas will lead the cosmetic wing of the Skin of Color Clinic. Her areas of expertise include chemical peels, laser hair removal and DPN, and skin tag/seborrheic keratosis removal.

“Dr. Oyerinde will excel as the director of the Skin of Color Clinic because of her dedication to providing personalized care for patients of all ethnicities, skin tones and hair textures,” Dr. Ida Orengo, professor and chair of dermatology at Baylor, adds. “The Skin of Color clinic will focus on the treatment of the diverse complexions of our patients and address the gaps in treatment while aiming to correct disparities and help ensure inclusivity in Houston healthcare.”

To further address those disparities, Dr. Oyerinde is planning community outreach events for potential Houston-area patients who may be unaware that clinics like this exist.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.